Luca Gianni
0000-0002-2372-9625
Fondazione Gianni Bonadonna
218 papers found
Refreshing results…
Pilot Trial of Trastuzumab Starting with or after the Doxorubicin Component of a Doxorubicin plus Paclitaxel Regimen for Women with HER2-Positive Advanced Breast Cancer
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
High-dose chemotherapy for breast cancer: any use for it?
Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
Anthracyclines.
The Future of Targeted Therapy: Combining Novel Agents
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer
Mechanism-Based Pharmacokinetic Model for Paclitaxel
Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer
Drug Interactions of Paclitaxel and Docetaxel and their Relevance for the Design of Combination Therapy
Clinical and Pharmacologic Study of the Epirubicin and Paclitaxel Combination in Women With Metastatic Breast Cancer
Adjuvant and neoadjuvant treatment of breast cancer
Response to Cyclophosphamide, Methotrexate, and Fluorouracil in Lymph Node–Positive Breast Cancer According to HER2 Overexpression and Other Tumor Biologic Variables
Long-Term Cardiac Sequelae in Operable Breast Cancer Patients Given Adjuvant Chemotherapy With or Without Doxorubicin and Breast Irradiation
Tolerability in patients receiving trastuzumab with or without chemotherapy
Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients
Missing publications? Search for publications with a matching author name.